Market News AIOpen the app

Pulmatrix shared its third quarter results for 2026 and updates on its merger with Eos SENOLYTIX.

DealRead the original at SEC EDGAR
Neutral

Pulmatrix has shareholder approval and an effective registration statement for its merger. Nasdaq approval and a reverse split are still required, and no quarter figures appear here, so the update does not change its outlook.

PULM · Pulmatrix, Inc.

AI read · Neutral

The AI's read

If completed, the merger would make Eos's business Pulmatrix's business. Shareholder approval and an effective registration statement move the deal closer. The deal still needs Nasdaq approval for the share listing and a reverse split. The supplied text gives no quarter figures, so it does not show a clear change in Pulmatrix's business outlook.

MNKD · MannKind Corporation

AI read · Neutral

The connection

MannKind is named as an iSPERSE licensee, but the update reports no new license terms, sales, or business change for MannKind.

Get alerts for PULM

Follow Pulmatrix, Inc. (PULM) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for PULM
Free on the App Store and Google Play, or on the web.